Decrease in multiple functions occurs in the brain with aging, all of which can contribute to age-related cognitive and locomotor impairments. Brain atrophy specifically in hippocampus, medial prefrontal cortex (mPFC), and striatum, can contribute to this age-associated decline in function. Our recent metabolomics analysis showed age-related changes in these brain regions. To further understand the aging processes, analysis using a proteomics approach was carried out. This study was conducted to identify proteome profiles in the hippocampus, mPFC, and striatum of 14-, 18-, 23-, and 27-month-old rats. Proteomics analysis using ultrahigh performance liquid chromatography coupled with Q Exactive HF Orbitrap mass spectrometry identified 1074 proteins in the hippocampus, 871 proteins in the mPFC, and 241 proteins in the striatum. Of these proteins, 97 in the hippocampus, 25 in mPFC, and 5 in striatum were differentially expressed with age. The altered proteins were classified into three ontologies (cellular component, molecular function, and biological process) containing 44, 38, and 35 functional groups in the hippocampus, mPFC, and striatum, respectively. Most of these altered proteins participate in oxidative phosphorylation (e.g. cytochrome c oxidase and ATP synthase), glutathione metabolism (e.g. peroxiredoxins), or calcium signaling pathway (e.g. protein S100B and calmodulin). The most prominent changes were observed in the oldest animals. These results suggest that alterations in oxidative phosphorylation, glutathione metabolism, and calcium signaling pathway are involved in cognitive and locomotor impairments in aging.
2015). Recently, transcriptomic studies on aging have reported links between age-related RNA and gene expression changes with significant biological processes and cellular responses (Brink et al. 2009; Lee et al. 2000; Yang et al. 2015) . Investigating the effect of aging at the proteome level may enhance our understanding of the cause and mechanisms of aging, particularly in the brain.
Proteomics study investigates the distribution, abundance, modifications, interactions, and function for sets of proteins (Aebersold and Mann 2003; Yarmush and Jayaraman 2002) . A number of studies have attempted to identify age-related protein alterations in the brain across various species, including mouse (Walther and Mann 2011) , rat (Ori et al. 2015) , and human (Manavalan et al. 2013) . Abnormalities in the proteome profile throughout aging were previously reported to be related with different processes, including glutamate regulation, protein synthesis, mitochondrial function, molecular transport, synaptic plasticity, and energy metabolism (Freeman et al. 2009; Manavalan et al. 2013; Poon et al. 2006; Stauch et al. 2015) . Considering that each brain region differs in its function, the identification of proteins changing with age in different rat brain regions will provide essential data to show interactions of these proteins in aging.
Our recent study reported that increased brain atrophy in the hippocampus, medial prefrontal cortex (mPFC), and striatum occurred between middle-to late-aged in rats, which was accompanied by impairment in learning, memory, and locomotor activity . Our metabolomics analysis of middle-to late-aged rat brains identified age-related changes in 38, 29, and 14 metabolites in the hippocampus, mPFC, and striatum, respectively, which were involved in multiple pathways including glutathione and purine metabolism ). To accompany our previous studies, we sought to identify age-related protein changes that would help us to understand molecular events of aging in the hippocampus, mPFC, and striatum, brain regions associated with learning, memory, or locomotor activity.
To date, the emergence of liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based proteomics has provided new opportunities for the large-scale comparison of the proteins between samples, with faster scanning mode, greater robustness, sensitivity, and accuracy (Scheltema et al. 2014) . Hence, the current study was conducted to identify potential proteins related biomarkers in the aging brain using this platform.
Materials and methods

Proteomes analysis in rat brain
Animals
Male Sprague-Dawley rats were purchased from Clea Japan, Inc. (Tokyo, Japan). The animals were maintained at room temperature under a 12-h light/dark cycle (lights on at 8 AM). Rats were housed two per cage with ad libitum access to food and water throughout the study period.
The rats were kept in transparent cages (40 cm × 25 cm × 20 cm) with non-enriched environments, therefore the possibility for the rats to exercise and explore was limited. However, animals were free to explore the cage and interact with one another. The same housing protocol was applied in a previous study where locomotor activity and exploration behavior were evaluated using open field test; the result demonstrated an age-dependent impairment in the exploration behavior of the rats .
All experimental procedures were carried out in accordance with the regulations of the Animal Care and Use Committee of Shiga University of Medical Science. The rats were divided into four age groups: 14, 18, 23, and 27 months old, and three rats were employed in each group. All of the rats used in the study were subjected to magnetic resonance imaging measurements and behavioral tests (open field, object recognition, and Morris water maze) as we reported ).
Brain tissue preparation
The rats were euthanized with inhaled isoflurane. Each brain was rapidly removed from the skull and rinsed in ice-cold 10 mM phosphate buffered saline. The brain was then sectioned into 2.0 to 3.0 mm coronal slices using a Rat Brain Slicer Matrix (Ted Pella, Inc., CA, USA), and further dissected into three different regions, hippocampus, mPFC, and striatum, on an ice-cold plate. Each sample was transferred into individual tubes, immediately weighed, frozen on dry ice, and stored at −80°C until analysis. The schematic overview of sample preparation workflow is summarized in Supplementary Fig. 1 .
Protein extraction
Proteins from the rat brain tissue were extracted according to a previous study with some modifications (Drew et al. 2005) . Each brain tissue was homogenized in 40 mM Tris/HCl pH 7.4, containing 3% dithiothreitol (Sigma Aldrich, St. Louis, MO, USA) and protease inhibitor cocktail (Roche, Mannheim, Germany) using an ultrasonicator (QSonica, Newtown, CT, USA). Subsequently, the homogenates were centrifuged at 20,600 ×g, 4°C, for 15 min and the resulting supernatants, which contains soluble proteins, were transferred to a new tube. The pellets were solubilized in thiourea rehydration buffer (a mixture of: 1 M urea (Sigma Aldrich, St. Louis, MO, USA), 2M thiourea (Wako, Tokyo, Japan), 4% 3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS) (Nacalai Tesque Inc., Kyoto, Japan), and 2% immobilized pH gradient (IPG) buffer (pH 3-10) (GE Healthcare BuiScience, Uppsala, Sweden), containing 0.28% dithiothreitol and protease inhibitor cocktail), followed by 15 min centrifugation at 20,600 ×g, 4°C. The use of IPG buffer in this mixture was to increase protein solubility (Rabilloud et al. 2007) . The supernatant was then pooled with the corresponding soluble fraction. A Bio-Rad Bradford protein assay kit (Bio-Rad, California, USA) was used to quantify protein concentrations in each sample. This extraction method was also applied for preparing protein samples for western blotting analysis.
Protein separation
Extracted protein (50 μg) from each sample was mixed with 5× sample buffer (0.1 M Tris-HCl pH 6.8, 1% sodium dodecyl sulfate (SDS), 20% glycerol, bromophenol blue) in ultrapure water (Merck Millipore, Billerica MA, USA), denatured for 5 min at 90°C in a thermomixer (Eppendorf, Hamburg, Germany) and resolved by 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at 120 V constant current. Each gel was washed three times with ultrapure water (Merck Millipore) for 5 min each time and stained for 60 min in Simply Blue Safe Stain (Invitrogen, USA). The gel was then washed twice with ultrapure water, 60 min for each wash.
In-gel digestion
In-gel digestion was conducted according to a published protocol with some modifications (Shevchenko et al. 2007 ). First, protein bands in the lanes for samples from the four age groups of each region and each rat were excised from the gel and fractionated into six fractions. Each fraction was diced into 1 to 2 mm pieces and transferred into microcentrifuge tubes. The gel plugs were destained in 100 μl of 50% acetonitrile in 50 mM ammonium bicarbonate, 15 min each time with shaking, repeated until the gel plugs were clear. The gel plugs were then incubated in 300 μl of 10 mM dithiothreitol in 100 mM ammonium bicarbonate for 30 min at 60°C followed by transfer to 300 μl of 55 mM iodoacetamide in 100 mM ammonium bicarbonate for 20 min in the dark. The gel plugs were again washed three times with 1 ml of 50% acetonitrile in 100 mM ammonium bicarbonate for 20 min each time and dehydrated with 100 μl of acetonitrile. The gel plugs were dried in a vacuum concentrator (Eppendorf) for 15 min at ambient temperature. Finally, 6 ng of trypsin in 50 mM ammonium bicarbonate was added to the dried gel plugs, which were incubated overnight at 37°C to allow for protein digestion.
After overnight digestion (approximately 18 h), the gel plugs were incubated with 100 μl of acetonitrile for 15 min with constant agitation. The supernatant was then transferred into a new tube and gel plugs reextracted with another 100 μl of 50% acetonitrile. Both supernatants were pooled, and then dried for about 3 h under vacuum at 30°C. The dried peptides from each tissue sample were reconstituted in 0.1% formic acid before analysis on the liquid chromatography-tandem mass spectrometry (LC-MS/MS) system.
LC-MS/MS analysis
Mass spectrometry (MS) analysis was performed using Q Exactive HF Orbitrap MS coupled to a Dionex Ultimate 3000 UHPLC instrument (Thermo Fisher Scientific, Waltham, MA, USA). Thermo Xcalibur MS data system software was used as the system controller. Six microliters of each extracted sample was injected onto a reversed phase PepMap-C18 pre-column with 20 μm inner diameter × 750 mm length, and chromatographed on a PepMap RSLC C18 2 μm, 100 Å, 75 μm × 25 cm (Thermo Fisher Scientific), at 35°C and separated using a binary gradient mobile phase system. The temperature of the auto-sampler was maintained at 0-10°C.
The binary gradient mobile phase consisted of water with 0.1% formic acid (solvent A) and, acetonitrile with 0.1% formic acid (solvent B). All chemicals used for LC-MS/MS procedure were of liquid chromatography-mass spectrometry (LC-MS) grade (Fisher Scientific, New Jersey, USA). The eluted peptides were separated using a linear gradient 5% B at t = 0, 7% B at t = 5 min, 25% B at t = 90 min, 60% B at t = 108 min, 95% B at t = 113 to 123 min, 2% B at t = 125 to 135 min. Total sample running time was 135 min with a constant flow of 0.3 μl/ min.
The data acquisition was performed in the electrospray ionization positive mode, with charge state + 2, capillary temperature 275°C, and spray voltage at 1.6 kV. Full scan MS spectra (scan range 350-1800 m/ z) were acquired at a resolution 120,000, an accumulation gain control (AGC) target of 3 × 10 6 , and a maximum injection time of 100 ms. MS/ MS spectra were operated at scan range 200-2000 m/z, mass resolution 15,000, AGC target 1 × 10 5 , maximum time 65 ms, high energy collision-induced dissociation (HCD) with a normalized collision energy (NCE) was set to 28% with 0.7 m/z isolation window. Only one Microscan was used for detection in all experiments. Full scans and Orbitrap MS/MS scans were acquired in profile mode.
Data analysis 2.2.1. Protein identification and label-free quantification
Mass spectra data acquired from the XCalibur software (Thermo Fisher Scientific) were processed using MaxQuant version 1.5.3.30 (http://www.maxquant.org), and searched by Andromeda search engine (Iovinella et al. 2015; Tyanova et al. 2016a ). The sequence database (Rattus norvegicus) used in the analysis were obtained from UniProt database (http://www.uniprot.org) accessed on March 2017. The spectra search included carbamidomethylation of cysteine as a fixed modification, while oxidation of methionine and acetylation of protein N-terminal were set as variable modifications. Trypsin was set as a specific enzymatic digestion with the maximum of two missed cleavages. As no labeling was performed, multiplicity was set to one. During the main search, parent masses were allowed an initial mass deviation of 4.5 ppm and fragment ions were allowed a mass deviation of 0.5 Da. Orbitrap was set as the instrument type. Common contaminants search was also included. Peptides with the minimum of seven amino acid length were considered. Peptide spectrum match (PSM) and protein identification were filtered using a target-decoy approach with a false discovery rate (FDR) of 1%. Protein identification required at least one unique or razor peptide per group. Label-free quantification (LFQ) was selected with MS/MS being required for LFQ comparison. LFQ of proteins was performed using the MaxLFQ algorithm integrated into MaxQuant. For protein quantification, minimum ratio count was set as two. All other MaxQuant settings were set as default (Tyanova et al. 2016a ). LFQ intensity is the relative protein quantification across all samples and is represented by a normalized intensity profile that is generated according to the algorithms as previously described (Cox et al. 2014) . The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Vizcaíno et al. 2013 ) partner repository with the dataset identifier PXD009212.
Protein quantification and statistical analysis
Perseus software (version 1.5.4.1, Max Planck Institute of Biochemistry, Martinsried, Germany) was used to perform bioinformatic and statistical analysis using the output file from MaxQuant (Tyanova et al. 2016b ). The MaxQuant data were filtered for protein identifications based on sites only, reverse identifications (false positives), and potential contaminants. The LFQ intensity ratios were log2 transformed. Rows were then filtered based on valid values with a minimum number of two in at least one group. Missing values were replaced by a normal distribution using imputation option. The LFQ intensities mean and standard error of the mean were calculated for all experimental groups in each brain region. In order to estimate the variabilities between biological replicates of the brain sample, principal component analysis was conducted using the Perseus software.
Analysis of variance (ANOVA) was used to test for significant difference between each group. Significant differences for each protein between specific age groups were determined using the Bonferroni post hoc test (GraphPad Prism 5, GraphPad Software; La Jolla, CA, USA). A protein was considered to be differentially expressed when the difference between groups had p value of less than 0.05 (p < 0.05). Data analysis workflow using MaxQuant and Perseus software are summarized in Supplementary Fig. 2 .
Protein annotation and gene ontology (GO) categories
The differentially expressed proteins were annotated using Blast2GO software version 5.0 (https://www.blast2go.com). Protein sequences were compared against SwissProt database using public NCBI Blast service (QBlast). The blast program was set as blastp-fast with blast expectation value (E-value) 1 × 10
, with rat taxonomic filter. Then, protein sequences were further analyzed using InterproScan, Mapping, and Annotation. The meaningful matches from Blast2GO analysis were subjected to GO categories (cellular component, molecular function, and biological process). GO graph was then generated using Web Gene Ontology Annotation Plot (WEGO) version 2.0 (http:// wego.genomics.org.cn), separately for each brain region. Data analysis workflow using Blast2GO software is summarized in Supplementary  Fig. 3. 
Pathway analysis
To interpret possible molecular mechanisms underlying aging, each of the protein in all regions was subjected to pathway search against Kyoto Encyclopedia of Genes and Genomes (KEGG) database (http:// www.genome.jp/kegg/pathway.html).
Western blotting
Protein extracts from the hippocampus of 14 and 27 months old rats were resolved on 15% SDS-PAGE gels (Wako, Japan) and transferred to nitrocellulose membranes, which were blocked by 10% skim milk in Tris-buffered saline (TBS; 25 mM Tris-HCl, pH 7.4, 0.9% NaCl) containing 0.1% Tween 20 (TBS-T), washed for 10 min with TBS-T, and incubated with primary antibodies: rabbit anti-calcium/calmodulin dependent protein kinase type II (CAMK2) (pan) (1:1000; Cell Signaling Technology, Danvers, MA, USA), mouse anti-S100 (1:1000; Millipore, Billerica, MA, USA), rabbit anti-calbindin (CALB1) (1:3000; Thermo, Pittsburgh, PA), and mouse anti-β-actin (ACTB) (1:5000; Santa Cruz Biotechnology, Dallas, TX, USA) in TBS-T at 4°C overnight. After washing three times for 10 min with TBS-T, the membrane was incubated with horseradish peroxidase-conjugated anti-rabbit (for CAMK2 and CALB1) and anti-mouse (for S100 and ACTB) IgG antibody (1:10,000; Jackson ImmunoResearch, West Grove, PA, USA) in TBS-T for 1 h at room temperature. The membrane was then washed three times for 10 min with TBS-T. Immunoreactive proteins were visualized by an enhanced chemiluminescence reagent (Chemi-Lumi One Super, Nacalai Tesque, Inc., Kyoto, Japan) using a lumino-image analyzer LAS-4000 (Fujifilm, Tokyo, Japan).
For semi-quantitative analysis, band intensities of the western blotting images were analyzed using Image Studio Lite version 5.2 software (LI-COR Biosciences, Lincoln, Nebraska, USA). Each band was manually selected and analyzed to obtain the density measurement. The ratios of the sample density to the internal reference (ACTB) were used and compared among the age groups (14 and 27 months old). The results were expressed as percentages relative to the control condition intensities (14 months old).
Results
Profiling of differentially expressed proteins in the brain
In order to investigate alterations in regional brain proteomes with age, we conducted a bioinformatic analysis of the LC-MS/MS data using MaxQuant and Perseus software. From these analyses, we identified 1074, 871, and 241 proteins in the hippocampus, mPFC, and striatum, respectively (Supplementary Tables S1-S3). Relative protein quantification among the three biological replicates of each group in the hippocampus (Fig. 1A) , mPFC (Fig. 1B) , and striatum (Fig. 1C) showed closely clustered samples between the groups, suggesting high consistency between each sample of hippocampus, mPFC, and striatum.
Protein levels in the hippocampus, mPFC, and striatum were calculated using MaxQuant and Perseus software, and the difference between the age groups were analyzed using ANOVA. Ninety-seven, 25, and 5 proteins showed altered expression levels with age in the hippocampus, mPFC, and striatum, respectively. These proteins are summarized in the Supporting Information Tables S4-S6 according to the classification of the protein function from Blast2GO annotation results. The complete lists of all identified and differentially expressed proteins are provided in Supporting Information Tables S1-S6.
Functional annotations of the proteins
GO annotation was performed using Blast2GO 5.0 to identify the GO functional groups of the differentially expressed proteins between the 14-, 18-, 23-, and 27-month-old groups in the rat hippocampus, mPFC, and striatum. The results showed that the 97 differentially expressed proteins in the hippocampus were successfully mapped with GO annotations, which were classified into three ontologies containing 44 functional groups ( Fig. 2A, Table S7 ). At the cellular component GO level, 14 GO terms were obtained, corresponding to 96 proteins (99%) in the cell (GO:0005623) and cell part category (GO:0044464), and 92 proteins (94.8%) were in the organelle category (GO:0043226). 10 GO terms were found for the molecular function ontology. The major functional groups were binding (GO:0005488), with 88 proteins (90.7%), and catalytic activity (GO:0003824), with 52 proteins (53.6%). At the biological process GO level, 20 GO terms were assigned. The major functional groups were involved in cellular process (GO:0009987), with 95 proteins (97.9%), followed by metabolic process (GO:0008152), including 80 proteins (82.5%).
Next, in mPFC (Fig. 2B, Table S7 ), the 25 differentially expressed proteins with age were mapped to 38 functional groups of the three GO annotations. 14 GO terms were assigned for the cellular component ontology, corresponding to 24 proteins (96%) in the cell (GO:0005623), cell part (GO:0044464), and organelle (GO:0043226) category. At molecular function GO level, six GO terms were obtained. The major functional groups in this category were binding (GO:0005488), with 20 proteins (80%), and catalytic activity (GO:0003824), with 15 proteins (60%). GO of biological process category in mPFC were assigned to 18 functional groups. The major functional groups were mainly involved in cellular process (GO:0009987), with 24 proteins (96%), followed by biological regulation (GO:0065007), including 19 proteins (76%).
The five differentially expressed proteins with age in the striatum (Fig. 2C , Table S7 ) were mapped to 35 functional groups of the three GO annotations. At cellular component GO level, 12 GO terms were obtained, corresponding to five proteins (100%) in cell (GO:0005623), cell part (GO:0044464), and membrane (GO:0016020) category. Five GO terms were mapped to molecular function, with major functional groups were binding (GO:0005488), with five proteins (100%), and catalytic activity (GO:0003824), with three proteins (60%). Meanwhile, 18 GO terms were assigned in the GO for the biological process in the striatum, with the majority of the proteins being involved in developmental process (GO:0032502), cellular process (GO:0009987), and response to stimulus (GO:0050896) with five proteins (100%).
Pathway analysis
The significantly altered proteins with age in the hippocampus, mPFC, and striatum (Table S4-S6) were subjected to query of the KEGG reference pathway database (http://www.genome.jp/kegg/pathway. html). Proteins were involved in oxidative phosphorylation (Fig. 3) , glutathione metabolism (Fig. 4) , and calcium signaling pathways (Fig. 5) .
In relation to oxidative phosphorylation (Fig. 3) , the expression levels of six proteins in hippocampus were increased (p < 0.05) with age ( Fig. 3A) : NADH dehydrogenase [ubiquinone] iron-sulfur protein 4 (NDUFS4), cytochrome b-c1 complex subunit 8 (UQCRQ), cytochrome c oxidase subunit 4 isoform 1 (COX4I1), cytochrome c oxidase subunit 5A (COX5A), ATP synthase subunit d (ATP5H), and ATP synthase subunit e (ATP5I). Meanwhile, in the medial prefrontal cortex (Fig. 3B) , the expression levels of two proteins were decreased (p < 0.05) with age: NADH-ubiquinone oxidoreductase chain 4 (MTND4) and cytochrome c oxidase subunit 1 (MTCO1).
The expression levels of five hippocampal proteins involved in glutathione metabolism (Fig. 4A) were increased (p < 0.05) at 23 and 27 months compared with the 14 months group: peroxiredoxin-1 (PRDX1), peroxiredoxin-2 (PRDX2), thioredoxin-dependent peroxide reductase (PRDX3), peroxiredoxin-5 (PRDX5), and glutathione Stransferase P (GSTP1). Meanwhile, superoxide dismutase [Cu-Zn] (SOD1) level was increased (p < 0.01) at 18, 23, and 27 months compared with 14 months in the same region (Fig. 4A ). In striatum (Fig. 4B) , glutathione S-transferase alpha-3 (GSTA3) level was increased (p < 0.05) at 23 months compared with the 14 months, while the SOD1 level was increased (p < 0.05) at 27 months compared with 14 and 18 months groups.
Furthermore, the expression levels of 10 proteins involved in a calcium signaling pathway (Fig. 5) were altered with age in the hippocampus. The expression levels of four proteins increased (p < 0.05) with age: calmodulin (CALM1), protein S100b (S100B), neurogranin (NRGN), and GTPase Hras (HRAS). In contrast, the levels of six proteins were decreased (p < 0.05) with age: glutamate receptor ionotropic, Nmethyl D-aspartate (NMDA) 2A (GRIN2A), glutamate receptor ionotropic, NMDA 2B (GRIN2B), guanine nucleotide-binding protein G(s) subunit alpha isoform short (GNAS), calcium/calmodulin-dependent protein kinase type II subunit alpha (CAMK2A), calcium/calmodulindependent protein kinase type II subunit beta (CAMK2B), and calcium/ calmodulin-dependent protein kinase type II subunit gamma (CAMK2G).
Validation of proteomics data analysis using semi-quantitative western blotting
Semi-quantitative western blotting analysis was carried out on several proteins (CAMK2A, CAMK2B, CALB1, S100B, and ACTB) to validate the proteome analysis data obtained by LC-MS/MS. Image of the band density of the proteins in the 14 and 27 months old rat hippocampus are shown in Fig. 6A . Western blotting analysis using specific antibodies against these proteins demonstrated decreased expression of CAMK2A (p < 0.05) (Fig. 6B ) and CAMK2B (p < 0.01) (Fig. 6C ) in 27 months old rats compared with the 14 months, while S100B was increased (p < 0.05) (Fig. 6D) . The expression of CALB1 (Fig. 6E) and ACTB (Fig. 6F) were unchanged. These findings were consistent with the protein expression result quantified by LC-MS/MS. Age-related decreased of CAMK2A and CAMK2B, as well as increased S100B were also observed in the hippocampus of 27 months old rats compared with the 14 months (Fig. 5) . In addition, CALB1 and ACTB were also unchanged in LC-MS/MS data (Table S1 ). This observation indicated, to the extent investigated with these selected proteins, that proteome data determined by LC-MS/MS appears reliable for the identification of agerelated change in protein expression.
Discussion
We identified a total of 2186 proteins using UHPLC coupled to Q Exactive HF Orbitrap mass spectrometry. Most of these proteins were detectable in the hippocampus and mPFC, but fewer in the striatum (Table S1-S3). Aging seemed to mostly affect proteins in the hippocampus region, with a total of 97 modulated proteins (Table S4) , while only 25 and five proteins were differentially regulated in the mPFC (Table S5 ) and striatum (Table S6) regions. The different protein that changed between brain regions might be related to unique functions of these regions. For example, hippocampus and mPFC regulate learning and memory (Euston et al. 2012; Good 2002) , while striatum is involved in locomotor activity (Kravitz and Kreitzer 2012) . Proteins altered with aging were analyzed for molecular function and biological process ontologies using Blast2GO in order to understand the potential impact of the protein changes. Ontological analysis indicated that proteins from various functions and processes, including antioxidant activity and signaling, were altered with aging (Fig. 2) . These differentially expressed proteins with age were mostly categorized in oxidative phosphorylation (Fig. 3) , glutathione metabolism (Fig. 4) , and calcium signaling pathway (Fig. 5) .
Our analysis displayed that the differentially expressed proteins with age were involved in oxidative phosphorylation (Fig. 3) in Fig. 1 . Principal component analysis of the proteomics data reveals replicates for each of the experimental group are closely clustered, suggesting high consistency between replicate runs in the rat (A) hippocampus, (B) medial prefrontal cortex, and (C) striatum.
H.S. Hamezah et al. Experimental Gerontology 111 (2018) 53-64 hippocampus and mPFC. Oxidative phosphorylation is a process of the mitochondrial electron transport chain that leads to production of ATP. Reactive oxygen species are generated as a byproduct of this metabolism, which are highly reactive and toxic at high levels, and can contribute to mitochondrial dysfunction (Liemburg-Apers et al. 2015) . Mitochondrial dysfunction has been implicated as one feature of normal aging (Payne and Chinnery 2015) . In hippocampus, proteins in most mitochondrial complexes such as NDUFS4 (complex I), UQCRQ (complex III), COX4I1 (complex IV), COX5A (complex IV), ATP5H (complex V), and ATP5I (complex V) were increased (p < 0.05) in the late-aged rats (Fig. 3A) . A previous study also reported age-related increased of mRNA expression in mice cerebral cortex in the complex I, III, IV, and V, suggesting as a compensatory mechanism to allow the production of proteins involved in electron transport chain (Manczak et al. 2005) . This is further supported by the increased expression of cytochrome oxidase subunits I and IV in the brains of rats aged 26 months compared with 12 months old (Fattoretti et al. 2004) . Nevertheless, aging promotes different regional changes, evident in our observations of lower protein expression of complex I and IV in the mPFC of the late-aged rats (27 months) (Fig. 3B) . Age-related decline in proteins involved in oxidative phosphorylation has also been implicated in rat hippocampal mitochondrial dysfunction (Navarro et al. 2008) . The different spatial expression of these proteins in hippocampus and mPFC is currently not understood and hence require further investigation. The disturbance in oxidative phosphorylation metabolism may cause increased oxidative stress in aging. Glutathione metabolism provides a critical defense system against oxidative stress. With age, several proteins involved in this pathway were increased in the lateaged rats including glutathione S-transferase (GST), peroxiredoxins (PRDX), and superoxide dismutase (SOD). GST is protective against reactive molecules such as electrophilic metabolites during oxidative stress by catalyzing the nucleophilic attack of glutathione on electrophilic substrates (Pajaud et al. 2012) . Both GSTP1 and GSTA3, proteins involved in oxidative stress regulation were upregulated in older rats (23 and/or 27 months) compared to younger rats (14 months) (Fig. 4) . Similarly, a previous study also reported increase of these two proteins in aged rat brain (Martínez-Lara et al. 2003) . Other than GST, PRDX is also involved in glutathione metabolism. PRDXs are thiol-specific antioxidant enzymes which possess six isoenzymes, namely, PRDX1, 2, 3, 4, 5, and 6 (Park et al. 2016). Our current findings showed increased Fig. 2 . Gene ontology (GO) classification for differentially expressed proteins in the rat (A) hippocampus, (B) medial prefrontal cortex, and (C) striatum. GO of the proteins were categorized into its cellular component, molecular function, and biological process. levels of PRDX1, 2, 3, and 5 in the hippocampus of the older rats (23 and 27 months) compared to the younger rats (14 months) (Fig. 4A ). In agreement with our finding, a recent transcriptomic study demonstrated increased expression of genes (GST, subunits mu1, mu3, mu7, pi2, theta 1, and theta2) in cerebral tissue of mice aged 30 months old (Frahm et al. 2017) . This is further supported by a metabolomic study which reported the upregulation in hippocampus of late-aged rats (23 and 27 months) of the metabolites reduced glutathione (GSSH), L-γ-glutamylcysteine, bis-γ-glutamylcysteine, and S-methylglutathione, which are involved in glutathione metabolism, suggesting a protective anti-oxidant compensatory mechanism in the late-aged rodent brain Furthermore, calcium signaling perturbation in aging brain can also greatly contribute to altered synaptic function and neurodegeneration (Foster 2007; Green and LaFerla 2008; Surmeier 2007) . In hippocampus, proteins related to calcium signaling (S100B, CALM1, NRGN, and HRAS) were significantly increased in aging rats (Fig. 5) . At low, physiological concentrations, S100B protects neurons against apoptosis, regulates synaptic plasticity, and stimulates neurite outgrowth and astrocyte proliferation (Businaro et al. 2006; Sorci et al. 2010) . Yet, at a high level, the protein might be toxic, participating in inflammatory responses, causing neuronal death, and exhibiting properties of a damage-associated molecular pattern protein (Sorci et al. 2010) . Elevated levels of S100B have been implicated in Alzheimer's and Parkinson's disease (Peskind et al. 2001; Rothermundt et al. 2003; Sathe et al. 2012) . Similarly, the level of CALM1 and its binding protein, NRGN, were also elevated in the hippocampus of the older rats compared with the younger ones (14 months) (Fig. 5) . Since NRGN binds to CALM1 in the absence of calcium to regulate calcium influx (Mons et al. 2001) , the elevated level of these proteins with age might possibly be an indicator for decreased calcium level in the hippocampus. In support of this, we also found the decreased expression of GRIN2A, GRIN2B, and ⁎ p < 0.05, ⁎⁎ p < 0.01. CAMK2 (Fig. 5) . Age-related decline of glutamate receptors (e.g. NMDA) in the hippocampus have been reported previously, leading to reduced calcium influx, which can contribute to impairments in cognitive and synaptic function (Barnes et al. 1997; Kumar et al. 2009; Magnusson 2012) . Meanwhile, CAMK2 dysregulation, especially in the hippocampus, has been suggested to be a key contributor to aberrant calcium signaling, synaptic dysfunction, neurodegeneration, and memory deficits (Ghosh and Giese 2015) . In addition, a previous study provided a link between age-related alterations in NMDA receptors with CAMK2 function (Bodhinathan et al. 2010) . Interactions between these proteins are important in modulation of synaptic plasticity and spatial learning (Zhou et al. 2007 ). Therefore, changes in the expression of these proteins may contribute to impairments in learning and memory (Lisman et al. 2002; Magnusson 2012 ). This finding is strengthened by our previous report on the impaired memory in the late-aged rat . Synaptic protein loss and gliosis are among the features of aging (Schulpis et al. 2001) . However, in this study, synaptic proteins such as synaptophysin (SYP) and synaptosomal-associated protein 25 (SNAP25), as well as the astrocyte-specific protein like glial fibrillary acidic protein (GFAP) were unchanged with age in hippocampus, mPFC, and striatum (Table S1-S3) . This finding contradicts with the previous studies which reported the age-related decline in the expression of SYP and SNAP25 (Canas et al. 2009 ), as well as increased expression of GFAP (O'Callaghan and Miller 1991) in the aging brain. The differences could be contributed by several factors such as difference in the rat strain or age group. For example, this study used male SpragueDawley rats aged 14 to 27 months. Conversely, the past studies used different rats strain (Wistar and Long-Evans) and utilized younger rats (2-3 months) (Canas et al. 2009; O'Callaghan and Miller 1991) . Additionally, differences in the method of analysis may also influence the results. Analyses of the proteins were performed using LC-MS/MS analysis, with one-dimensional gel electrophoresis sample fractionation, while the previous studies utilized western blotting and radioimmunoassay (Canas et al. 2009; O'Callaghan and Miller 1991) .
The present study provides initial insights into understanding protein changes with aging in specific brain regions. We found that the proteins were not consistently changed between the three brain regions (hippocampus, mPFC, and striatum). Overall, these changes were mostly observed in the late-aged (27 months old) rats when compared with the middle-aged (14 months old) animals. This finding is supported by our previous study that demonstrated brain atrophy, as well as cognitive and locomotor deficits which were marked in the 27 months old rats compared with the 14 months ). Yet, the links between these proteins with memory, locomotor activity, brain volume, and metabolites are currently not understood and warrant further investigation.
The current study focused on the middle-(14 and 18 months) to late-aged rats (23 and 27 months) and did not include younger rats. The choice of rats with these ages (14, 18, 23, and 27 months) is based on our earlier findings Hamezah et al. 2017 ).
Previously, we have performed behavioral tests and magnetic resonance imaging on these rats and we found a significant cognitive and locomotor impairment, as well as brain atrophy in the late-aged (27 months) compared to the middle-aged (14 months) rats ). In addition, we also have conducted a metabolomic analysis using LC-MS/MS on these rats, which demonstrated significant metabolic changes with age in these rats' hippocampus, mPFC, and striatum . Hence, we carried out proteomics study on these rats in order to further our understanding of proteome changes in the brain of these four age groups. In support of this, an in vivo study also showed that age-related hippocampal volume decline in the lateaged (28 months) rats compared with the middle-aged (18 months), whereas the volume was increased in middle-aged (18 months) compared to young age (6 months) (Lu et al. 2014 ).
In future, further studies can be implemented to validate the role of these proteins in age-related decline in brain function. Limitations of this study were the number of biological replicates in each age group. Confirmation of these promising findings, along with the inclusion of aged animals of both genders, younger age-groups, and inclusion of treatments that might alter age-related declines can be considered. Gender differences have been reported in a previous study, which detected 33 differentially expressed proteins between male and female rodent hippocampus (Yang et al. 2013) . The protective effects of estrogen in female brain with aging has been extensively studied (Norbury et al. 2003; Zárate et al. 2017) , so further investigations of protein alterations with age in both male and female rats need to be conducted to enhance our understanding of aging brain mechanisms.
Conclusion
The present study identified 97, 25, and 5 proteins as age-related proteins in the hippocampus, mPFC, and striatum, respectively. These altered proteins participated in oxidative phosphorylation, glutathione metabolism, and calcium signaling pathway, with the most prominent changes being observed in the oldest group of animals. These results Fig. 6 . Validation of indicated proteins in hippocampus of 14 and 27 months old rats by western blotting analysis. (A) Band density of calcium/calmodulin dependent protein kinase type II subunit alpha (CAMK2A), calcium/calmodulin dependent protein kinase type II subunit beta (CAMK2B), S100B, calbindin (CALB1), and β-actin (ACTB). The result demonstrated decrease expression of (B) CAMK2A and (C) CAMK2B, whereas increase expression of (D) S100B in the 27 months old rat hippocampus, compared with the 14 months. (E) CALB1 and (F) ACTB, as an internal control, were unchanged. Data are presented as mean ± S.E.M. suggest that alterations in oxidative phosphorylation, glutathione metabolism, and calcium signaling pathway may be involved in cognitive and locomotor impairments in aged rats.
